Vendor, Raritan, NJ, part of Johnson & Johnson
Janssen Research & Development, LLC
UEI CDACRW7YFNR7, CAGE 7QUB7
1 award and $2,530,189 obligated between March 15, 2024 and September 26, 2025, 100% under full and open competition, against 1.0 offers on average where reported.
Sells to
Awarding agencies by dollars.
| Office of Assistant Secretary for Preparedness and Response | $2,530,189 |
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $2,530,189 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75A50118C00012Definitive Contract, March 15, 2024, Full and Open Competition, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Janssen - Tpom Ot AgreementNAICS 541714, PSC AN13 | $2,530,189 |
- Places of performance
- New Jersey
- Product and service codes
- AN13 Health R&D Services; Health Care Services; Experimental Development
- Transactions
- 6 across 1 awards